Nicolas Kahn

4.7k total citations · 1 hit paper
61 papers, 2.1k citations indexed

About

Nicolas Kahn is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Surgery. According to data from OpenAlex, Nicolas Kahn has authored 61 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Pulmonary and Respiratory Medicine, 14 papers in Physiology and 6 papers in Surgery. Recurrent topics in Nicolas Kahn's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (26 papers), Sarcoidosis and Beryllium Toxicity Research (12 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (10 papers). Nicolas Kahn is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (26 papers), Sarcoidosis and Beryllium Toxicity Research (12 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (10 papers). Nicolas Kahn collaborates with scholars based in Germany, Netherlands and United States. Nicolas Kahn's co-authors include Michael Kreuter, Felix Herth, Thomas Muley, Michael Meister, Marc A. Schneider, Carmen Veith, Agnes W. Boots, H. Winter, Bianca P. Hennig and Timo B. Trefzer and has published in prestigious journals such as The EMBO Journal, Neurology and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

Nicolas Kahn

54 papers receiving 2.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

SARS ‐CoV‐2 receptor ACE 2 and TMPRSS 2 are primarily expressed in bronchial transient secretory cells

2020 703 citations Soeren Lukassen, Robert Lorenz Chua et al. The EMBO Journal profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Nicolas Kahn Germany	17	906	749	284	266	240	61	2.1k
Huaping Dai China	13	529 0.6×	597 0.8×	351 1.2×	253 1.0×	139 0.6×	44	1.5k
Li Niu China	16	322 0.4×	1.2k 1.7×	669 2.4×	266 1.0×	335 1.4×	43	2.2k
Benjamin Wilde Germany	31	755 0.8×	479 0.6×	85 0.3×	306 1.2×	218 0.9×	117	2.5k
Josephine L. Barnes United Kingdom	9	293 0.3×	1.2k 1.5×	500 1.8×	506 1.9×	139 0.6×	10	2.2k
Lavannya M. Pandit United States	13	261 0.3×	649 0.9×	441 1.6×	241 0.9×	118 0.5×	21	1.2k
Ping Peng China	18	325 0.4×	529 0.7×	520 1.8×	301 1.1×	145 0.6×	89	1.6k
Arun Kumar Nalla United States	19	498 0.5×	1.7k 2.3×	784 2.8×	519 2.0×	501 2.1×	26	2.9k
Marijn Berg Netherlands	6	223 0.2×	1.1k 1.5×	500 1.8×	255 1.0×	122 0.5×	14	1.8k
Jun Young Lee South Korea	21	315 0.3×	330 0.4×	140 0.5×	336 1.3×	180 0.8×	107	1.8k

Countries citing papers authored by Nicolas Kahn

Since Specialization

Citations

This map shows the geographic impact of Nicolas Kahn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicolas Kahn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicolas Kahn more than expected).

Fields of papers citing papers by Nicolas Kahn

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicolas Kahn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicolas Kahn. The network helps show where Nicolas Kahn may publish in the future.

Co-authorship network of co-authors of Nicolas Kahn

This figure shows the co-authorship network connecting the top 25 collaborators of Nicolas Kahn. A scholar is included among the top collaborators of Nicolas Kahn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nicolas Kahn. Nicolas Kahn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ganter, Claudia, Marlies Wijsenbeek, Nicolas Kahn, et al.. (2024). Is YouTube a sufficient source of information on Sarcoidosis?. Respiratory Research. 25(1). 334–334. 1 indexed citations

Veith, Carmen, Marc A. Schneider, Albert van der Vliet, et al.. (2023). Differences in Treatment Response in Bronchial Epithelial Cells from Idiopathic Pulmonary Fibrosis (IPF) Patients: A First Step towards Personalized Medicine?. Antioxidants. 12(2). 443–443. 1 indexed citations

Ganter, Claudia, Marlies Wijsenbeek, Nicolas Kahn, et al.. (2023). Is the internet a sufficient source of information on sarcoidosis?. Frontiers in Medicine. 10. 1217146–1217146. 2 indexed citations

Enderle, Markus D., Nicolas Kahn, Markus Polke, et al.. (2022). Establishment of a Tissue-Mimicking Surrogate for Pulmonary Lesions to Improve the Development of RFA Instruments and Algorithms. Biomedicines. 10(5). 1100–1100. 2 indexed citations

Trinkmann, Frederik, Michael Müller, Nicolas Kahn, et al.. (2021). Residual symptoms and lower lung function in patients recovering from SARS-CoV-2 infection. European Respiratory Journal. 57(2). 2003002–2003002. 27 indexed citations

Röhrich, Manuel, Dominik Leitz, Annika K. Wefers, et al.. (2021). Fibroblast Activation Protein–Specific PET/CT Imaging in Fibrotic Interstitial Lung Diseases and Lung Cancer: A Translational Exploratory Study. Journal of Nuclear Medicine. 63(1). 127–133. 105 indexed citations

Torrisi, Sebastiano Emanuele, Nicolas Kahn, Julia Wälscher, et al.. (2021). Outcomes and Incidence of PF-ILD According to Different Definitions in a Real-World Setting. Frontiers in Pharmacology. 12. 790204–790204. 12 indexed citations

Lukassen, Soeren, Robert Lorenz Chua, Timo B. Trefzer, et al.. (2020). SARS-CoV-2 receptor ACE2 and TMPRSS2 are primarily expressed in bronchial transient secretory cells. The EMBO Journal. e105114–e105114. 253 indexed citations

Lukassen, Soeren, Robert Lorenz Chua, Timo B. Trefzer, et al.. (2020). SARS ‐CoV‐2 receptor ACE 2 and TMPRSS 2 are primarily expressed in bronchial transient secretory cells. The EMBO Journal. 39(10). e105114–e105114. 703 indexed citations breakdown →

10.

Polke, Markus, D Kirsten, Birgit Teucher, et al.. (2020). A Comparison of Existing Questionnaires for Identifying the Causes of Interstitial and Rare Lung Diseases. Respiration. 99(2). 119–124. 9 indexed citations

11.

Koczulla, Andreas Rembert, Tobias Boeselt, Christoph Nell, et al.. (2020). Effects of Vibration Training in Interstitial Lung Diseases: A Randomized Controlled Trial. Respiration. 99(8). 658–666. 2 indexed citations

12.

Torrisi, Sebastiano Emanuele, Nicolas Kahn, Julia Wälscher, et al.. (2019). Possible value of antifibrotic drugs in patients with progressive fibrosing non-IPF interstitial lung diseases. BMC Pulmonary Medicine. 19(1). 213–213. 18 indexed citations

13.

Chaudhuri, Nazia, et al.. (2019). The therapy of idiopathic pulmonary fibrosis: what is next?. European Respiratory Review. 28(153). 190021–190021. 187 indexed citations

14.

Fritzsching, Benedikt, Zhe Zhou-Suckow, Joanna Trojanek, et al.. (2015). Hypoxic Epithelial Necrosis Triggers Neutrophilic Inflammation via IL-1 Receptor Signaling in Cystic Fibrosis Lung Disease. American Journal of Respiratory and Critical Care Medicine. 191(8). 902–913. 81 indexed citations

15.

Kahn, Nicolas, J. Riedlinger, Markus Roeßler, et al.. (2015). Blood-sampling collection prior to surgery may have a significant influence upon biomarker concentrations measured. Clinical Proteomics. 12(1). 19–19. 9 indexed citations

16.

Oltmanns, Ute, Karin Palmowski, Mark O. Wielpütz, et al.. (2015). Optical coherence tomography detects structural abnormalitiesof the nasal mucosa in patients with cystic fibrosis. Journal of Cystic Fibrosis. 15(2). 216–222. 17 indexed citations

17.

Oltmanns, Ute, Nicolas Kahn, Heinrich Wenz, et al.. (2013). Pirfenidone in idiopathic pulmonary fibrosis - Real life experience from a german tertiary referral centre for interstitial lung diseases. European Respiratory Journal. 42(Suppl 57). P2335–P2335. 4 indexed citations

18.

Herth, Felix, Helena Garcia Schüler, Daniela Gompelmann, et al.. (2011). Endobronchial ultrasound-guided lymph node biopsy with transbronchial needle forceps: a pilot study. European Respiratory Journal. 39(2). 373–377. 46 indexed citations

19.

Eberhardt, Ralf, Nicolas Kahn, & Felix Herth. (2010). ‘Heat and Destroy’: Bronchoscopic-Guided Therapy of Peripheral Lung Lesions. Respiration. 79(4). 265–273. 19 indexed citations

20.

Kahn, Nicolas, Ruprecht Kuner, Ralf Eberhardt, et al.. (2009). Gene expression analysis of endobronchial epithelial lining fluid in the evaluation of indeterminate pulmonary nodules. Journal of Thoracic and Cardiovascular Surgery. 138(2). 474–479. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact